In our study, after cell therapy, the most prominent pro-angiogenic genes (Vegf-a, Vegf-b, and Vegf-c) and their receptors (Flt-1 and Kdr) were upregulated in the myocardium 3 months after MI induction. The gene discussed is VEGFC; the disease is myocardial infarction.